title: Use of anti-hepatitis C virus seropositive organs in liver transplantation.
authors.affiliation: Division of Transplantation Services, Baylor University Medical Center, Dallas, Texas 75246.
authors.forename: D C
authors.initials: DC
authors.lastname: Mulligan
authors.forename: R M
authors.initials: RM
authors.lastname: Goldstein
authors.forename: J S
authors.initials: JS
authors.lastname: Crippin
authors.forename: M S
authors.initials: MS
authors.lastname: Abouljoud
authors.forename: M F
authors.initials: MF
authors.lastname: Levy
authors.forename: B S
authors.initials: BS
authors.lastname: Husberg
authors.forename: T A
authors.initials: TA
authors.lastname: Gonwa
authors.forename: B R
authors.initials: BR
authors.lastname: Foster
authors.forename: G W
authors.initials: GW
authors.lastname: Tillery
authors.forename: G B
authors.initials: GB
authors.lastname: Klintmalm
mesh_terms: D000704:Analysis of Variance; D005260:Female; D005500:Follow-Up Studies; D016174:Hepacivirus / Q000302:isolation & purification*; D006526:Hepatitis C / Q000453:epidemiology*; D006801:Humans; D008099:Liver / Q000473:pathology / Q000821:virology*; D016031:Liver Transplantation / Q000401:mortality / Q000473:pathology / Q000502:physiology*; D008297:Male; D011183:Postoperative Complications / Q000453:epidemiology*; D011336:Probability; D012008:Recurrence; D012307:Risk Factors; D015996:Survival Rate; D013997:Time Factors